We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

1 hedge funds and large institutions have $34.3M invested in Ariad Pharmaceuticals Inc in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 191 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% less funds holding in top 10

Funds holding in top 10: 9 → 1 (-8)

98% less capital invested

Capital invested by funds: $2.13B → $34.3M (-$2.09B)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 191

100% less funds holding

Funds holding: 200 → 1 (-199)

Holders
1
Holders Change
-199
Holders Change %
-99.5%
% of All Funds
0.02%
Holding in Top 10
1
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-88.89%
% of All Funds
0.02%
New
1
Increased
–
Reduced
–
Closed
191
Calls
$31K
Puts
–
Net Calls
+$31K
Net Calls Change
+$16.5M

Top Buyers

Rank Fund Capital Flow
1
FPF
FNY Partners Fund
New York
+$32M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$225M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$218M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$182M
4
SCM
Sarissa Capital Management
Connecticut
-$160M
5
State Street
State Street
Massachusetts
-$97.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
101
D.E. Shaw & Co
New York
– -$809K -65,062 Closed
VKH
102
Virtu KCG Holdings
New York
– -$752K -60,428 Closed
Russell Investments Group
103
Russell Investments Group
United Kingdom
– -$746K -60,142 Closed
RB
104
Rodgers Brothers
Pennsylvania
– -$718K -57,680 Closed
RA
105
Royce & Associates
New York
– -$690K -55,502 Closed
Federated Hermes
106
Federated Hermes
Pennsylvania
– -$636K -51,144 Closed
TI
107
Trexquant Investment
Connecticut
– -$616K -49,529 Closed
Royal Bank of Canada
108
Royal Bank of Canada
Ontario, Canada
– -$586K -47,187 Closed
Capital Fund Management (CFM)
109
Capital Fund Management (CFM)
France
– -$586K -47,102 Closed
SGAM
110
Steinberg Global Asset Management
Florida
– -$586K -47,100 Closed
CWM
111
Concert Wealth Management
California
– -$500K -40,399 Closed
LTFS
112
Ladenburg Thalmann Financial Services
Florida
– -$492K -39,602 Closed
OAM
113
Oxford Asset Management
United Kingdom
– -$490K -39,415 Closed
Mirae Asset Global Investments
114
Mirae Asset Global Investments
South Korea
– -$488K -39,283 Closed
Simplex Trading
115
Simplex Trading
Illinois
– -$477K -38,420 Closed
SGAM
116
Smith Group Asset Management
Texas
– -$451K -36,250 Closed
Public Employees Retirement Association of Colorado
117
Public Employees Retirement Association of Colorado
Colorado
– -$449K -36,086 Closed
CCMH
118
Cornerstone Capital Management Holdings
New York
– -$418K -33,617 Closed
FSA
119
Franklin Street Advisors
North Carolina
– -$418K -33,600 Closed
BCM
120
Bayesian Capital Management
New York
– -$381K -30,600 Closed
HSBC Holdings
121
HSBC Holdings
United Kingdom
– -$379K -30,480 Closed
Jane Street
122
Jane Street
New York
– -$377K -30,340 Closed
LCM
123
Laurion Capital Management
New York
– -$373K -30,000 Closed
TCT
124
TIAA CREF Trust
Missouri
– -$373K -30,000 Closed
PA
125
Pinnacle Associates
New York
– -$369K -29,680 Closed
3 4
5
6 7

ARIA Hedge Fund Activity: Q1 2017 in Review

1 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q1 2017, worth a combined $34.3M — down 98% from $2.13B a quarter earlier.

Sellers outnumbered buyers: 191 funds closed out of ARIA and 1 opened new positions — a net loss of 190 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was FNY Partners Fund, opening a new position worth an estimated $32M. The largest seller was Fidelity Investments, exiting entirely with an estimated $225M sold.

  • 1 institutional investor held Ariad Pharmaceuticals Inc (ARIA) as of Q1 2017, down from 200 in Q4 2016.
  • Funds reported $34.3M of Ariad Pharmaceuticals Inc stock for Q1 2017, down 98% quarter-over-quarter.
  • 1 fund opened new Ariad Pharmaceuticals Inc positions in Q1 2017 and 191 closed out, a net change of -190 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q1 2017 was FNY Partners Fund, an estimated $32M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q1 2017 was Fidelity Investments, an estimated $225M sold.

Based on aggregated 13F filings for Q1 2017.